Rocket Lab earnings analysis: questions answered and next catalysts
Investing.com reports Rocket Lab (RKLB) beat Q2 revenue with $234M (+62% YoY) but missed EPS at -$0.08 vs -$0.06 expected. Q3 revenue guidance is $250M–$265M, while GAAP gross margins are guided to 29%–31% and operating cash flow was a $84.1M use. Backlog is $2.4B and Neutron launch is targeted for Q4 2026.
How this was made
The 30-second read
Why it matters
Q2 revenue beat and a record $2.4B backlog are offset by weaker-than-expected EPS and, more importantly, Q3 gross margin guidance (29%-31%) and widening adjusted EBITDA losses, setting up a margin-recovery debate into the next earnings print.
Market read
Traders will likely reprice RKLB around the credibility of Neutron milestones and whether margin compression is a temporary investment phase, with the next major check at Q3 2026 earnings.
What to watch
The article notes the ATM offering was terminated and cash is $2.4B, but it does not quantify future funding needs beyond the stated runway, which could be a key swing factor if Neutron costs run hotter than guided.
Background
The piece is an earnings analysis for Rocket Lab, focusing on Q2 results and forward guidance tied to Neutron development and defense contracts.
Ticker impact
Rocket Lab guided Q3 revenue to $250M-$265M but projected GAAP gross margins of 29%-31%, signaling margin pressure from Neutron development costs.
Choppy-to-down bias possible until Q3 margin trajectory is clarified, with upside if Neutron milestones de-risk the backlog conversion narrative.
The article provides concrete Q3 guidance ranges, margin and EBITDA loss expectations, and specific Neutron timeline milestones (Q4 2026 pad delivery, engine hot-fire progress), which can drive repricing around the next earnings date.
Market effects
Reinforces the space launch and defense satellite supply chain narrative that near-term profitability may lag while next-gen vehicles and engines are funded.
European manufacturing and Mynaric production are framed as potential EU defense enablers, but no immediate regional datapoint is disclosed.
Defense satellite awards and Neutron validation are positioned as read-through for government space procurement and medium-lift market expectations.
Counterpoint
Margin compression could be temporary and already priced in after the stock’s ~40% three-month decline, making the guidance less bearish than it appears.
Key entities
- companyRocket Lab USA
Guided Q3 revenue $250M-$265M with GAAP gross margins 29%-31% and discussed Neutron timeline and defense contract awards.
- programNeutron
Next-generation launch system discussed with milestones including Q4 2026 pad delivery and Archimedes engine hot-fire progress.
- contractSpace Force Flatellite contract
$397M award described as airborne threat tracking satellites launched on Neutron.
- contractHASTE missile defense contract
$266M award described as missile defense work tied to Rocket Lab’s defense pipeline.
